Stratasys, Ltd.NASDAQ: SSYS

Stratasys Releases Second Quarter 2022 Financial Results

· Issued by Stratasys, Ltd. via Business Wire
  • Second quarter revenue of $166.6 million, 13.3% growth over second quarter 2021 (16.4% on a constant currency basis), highest second quarter revenue in four years
  • Second quarter GAAP net loss of $24.4 million, or $0.37 per diluted share, and non-GAAP net income of $1.2 million, or $0.02 per diluted share
  • $441.5 million cash and equivalents and no debt as of June 30, 2022
  • Updates 2022 full-year outlook adjusted for currency exchange impact

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)-- Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the second quarter of 2022.

Summary - Second Quarter 2022 Financial Results Compared to Second Quarter 2021:

  • Revenue of $166.6 million, compared to $147.0 million.
  • GAAP gross margin of 40.5%, compared to 43.0%.
  • Non-GAAP gross margin of 47.6%, compared to 47.5%.
  • GAAP operating loss of $23.5 million, compared to a GAAP operating loss of $22.7 million.
  • Non-GAAP operating income of $1.9 million, compared to non-GAAP operating loss of $2.6 million.
  • GAAP net loss of $24.4 million, or ($0.37) per diluted share, compared to net loss of $20.2 million, or ($0.31) per diluted share.
  • Non-GAAP net income of $1.2 million, or $0.02 per diluted share, compared to non-GAAP net loss of $1.6 million, or ($0.02) per diluted share.
  • Adjusted EBITDA of $7.4 million, compared to $3.5 million.
  • $22.8 million of cash used by, compared to $5.6 million of cash generated from, operating activities, reflecting a continued augmentation of inventories.

“Our continued focus on execution delivered strong growth in revenue, margin, and earnings per share,” commented Dr. Yoav Zeif, Stratasys’ Chief Executive Officer. “Systems was again the main driver of robust performance, growing 29.2% from the prior year period and 9.7% over the same period in 2019. Our new Origin P3 and H350 SAF mass production manufacturing systems continue to ramp, with excellent customer engagement across all of our new technology offerings.”

Dr. Zeif continued, “We are advancing our leadership position by executing on our strategic initiatives and steadily expanding our reach into Fortune 500 manufacturing facilities worldwide. We continue to provide best-in-class, full-scale 3D printing solutions through our innovative and growing ecosystem of polymer additive manufacturing systems, expanding variety of materials, end-to-end software and top quality service. With our robust balance sheet and leading go-to-market strategy, we are well-positioned to navigate challenging supply issues and global inflation in our efforts to create long-term value for all of our shareholders.”

Financial Outlook:

Based on current market conditions and assuming that the impact of the COVID-19 pandemic, global supply chain costs, currency risk and inflation do not impede economic activity further, the Company is updating its outlook for 2022 as follows:

  • Full year revenue of $675 million to $685 million, as compared to a previous range of $685 million to $695 million. The reduction is primarily due to unexpected and adverse currency exchange rates which are expected to impact third and fourth quarter results relatively equally.
  • Revenue growth in the second half of the year approximately 6%-7% higher than the second half of 2021, with fourth quarter anticipated to grow at a higher rate than third quarter.
  • Based on current logistics and materials costs, third quarter gross margins relatively flat compared to third quarter of 2021, and full-year gross margins of flat to slightly higher than 2021.
  • Full year-operating expenses that are $18 million to $23 million higher than 2021, primarily due to ongoing investments in new products to drive higher revenue.
  • Full year non-GAAP operating margins slightly above 2%.
  • GAAP net loss of $78 million to $69 million, or ($1.17) to ($1.04) per diluted share.
  • Non-GAAP net income of $10 million to $13 million, or $0.14 to $0.19 per diluted share.
  • Adjusted EBITDA of $38 million to $41 million.
  • Capital expenditures of $20 million to $25.

Non-GAAP earnings guidance excludes $37 million to $38 million of projected amortization of intangible assets, $33 million to $35 million of share-based compensation expense, and reorganization and other expenses of $14 million to $16 million. Non-GAAP guidance includes tax adjustments of $2 million to $1 million on the above non-GAAP items.

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

Stratasys Ltd. Second Quarter 2022 Webcast and Conference Call Details:

The Company plans to webcast its conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022, at 8:30 a.m. (ET).

The investor conference call will be available via live webcast on the Stratasys website at investors.stratasys.com, or directly at the following web address:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=mUfZ38Qo

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

The statements in this press release regarding Stratasys' strategy, and the statements regarding Stratasys’ projected future financial performance, including the financial guidance concerning its expected results for 2022 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the degree of our success at locating and acquiring additional value-enhancing, inorganic technology that furthers our business plan to lead in the realm of polymers; the potential adverse impact that recent global interruptions and delays involving freight carriers and other third parties (including due to the Russian invasion of Ukraine) may have on our supply chain and distribution network, and, consequently, our ability to successfully sell both our existing and newly-launched 3D printing products; the strength and duration of, and degree of recovery from and resilience to, the COVID-19 pandemic and/or adverse macro-economic trends that are, in part, by-products of that pandemic, such as inflation, which may have significant consequences for our operations, financial position, cash flows, and those of our customers and suppliers going forward; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2021, which we filed with the U.S. Securities and Exchange Commission, or SEC, on February 24, 2022 (the “2021 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2021 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2022, which will be furnished to the SEC throughout 2022, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of Non-GAAP Financial Measures

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

Stratasys Ltd.

 
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)

June 30,

December 31,

2022

2021

 
 
ASSETS
 
Current assets
Cash and cash equivalents

$

255,886

$

243,179

Short-term deposits

182,429

259,000

Accounts receivable, net of allowance for credit losses of $1.0 million and $0.5 millionas of June 30, 2022 and December 31, 2021

132,343

129,382

Inventories

153,702

129,147

Prepaid expenses

8,225

6,871

Other current assets

49,615

33,123

 
Total current assets

782,200

800,702

 
Non-current assets
Property, plant and equipment, net

192,630

203,295

Goodwill

64,959

65,144

Other intangible assets, net

133,657

152,244

Operating lease right-of-use assets

12,319

14,651

Long-term investments

31,191

28,667

Other non-current assets

12,886

12,519

 
Total non-current assets

447,642

476,520

 
Total assets

$

1,229,842

$

1,277,222

 
LIABILITIES AND EQUITY
 
Current liabilities
Accounts payable

$

61,316

$

51,976

Accrued expenses and other current liabilities

52,049

55,358

Accrued compensation and related benefits

30,513

44,684

Deferred revenues - short term

49,511

51,174

Operating lease liabilities - short term

6,111

7,276

 
Total current liabilities

199,500

210,468

 
Non-current liabilities
Deferred revenues - long term

22,727

21,133

Deferred income taxes - long term

4,511

7,341

Operating lease liabilities - long term

6,165

7,693

Contingent consideration - long term

50,299

53,478

Other non-current liabilities

22,931

21,095

 
Total non-current liabilities

106,633

110,740

 
Total liabilities

306,133

321,208

 
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands
shares; 66,744 thousands shares and 65,677 thousands shares issued
and outstanding at June 30, 2022 and December 31, 2021, respectively

186

182

Additional paid-in capital

3,030,088

3,012,481

Accumulated other comprehensive loss

(13,354

)

(8,771

)

Accumulated deficit

(2,093,211

)

(2,047,878

)

923,709

956,014

 
Total liabilities and equity

$

1,229,842

$

1,277,222

Stratasys Ltd.

 
Consolidated Statements of Operations
 
(in thousands, except per share data)
 

Three Months Ended June 30,

Six Months Ended June 30,

2022

2021

2022

2021

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Net sales
Products

$

115,721

$

100,305

$

228,794

$

190,629

Services

50,882

46,700

101,238

90,565

166,603

147,005

330,032

281,194

 
Cost of sales
Products

61,132

49,731

120,505

96,651

Services

38,078

34,004

72,457

65,696

99,210

83,735

192,962

162,347

 
Gross profit

67,393

63,270

137,070

118,847

 
Operating expenses
Research and development, net

24,346

22,437

48,344

43,038

Selling, general and administrative

66,592

63,557

131,855

116,891

90,938

85,994

180,199

159,929

 
Operating loss

(23,545

)

(22,724

)

(43,129

)

(41,082

)

 
Financial expenses, net

(1,170

)

(372

)

(2,532

)

(749

)

 
Loss before income taxes

(24,715

)

(23,096

)

(45,661

)

(41,831

)

 
Income tax benefit

429

4,368

502

5,310

 
Share in losses of associated companies

(99

)

(1,431

)

(174

)

(2,549

)

 
Net loss

$

(24,385

)

$

(20,159

)

$

(45,333

)

$

(39,070

)

 
Net loss per share
Basic

$

(0.37

)

$

(0.31

)

$

(0.69

)

$

(0.63

)

Diluted

$

(0.37

)

$

(0.31

)

$

(0.69

)

$

(0.63

)

 
Weighted average ordinary shares outstanding
Basic

66,568

64,908

66,151

61,796

Diluted

66,568

64,908

66,151

61,796

Three Months Ended June 30,

2022

Non-GAAP

2022

2021

Non-GAAP

2021

GAAP

Adjustments

Non-GAAP

GAAP

Adjustments

Non-GAAP

U.S. dollars and shares in thousands (except per share amounts)

Gross profit (1)

$

67,393

$

11,914

$

79,307

$

63,270

$

6,616

$

69,886

Operating income (loss) (1,2)

(23,545

)

25,479

$

1,934

(22,724

)

20,133

$

(2,591

)

Net income (loss) (1,2,3)

(24,385

)

25,560

$

1,175

(20,159

)

18,581

$

(1,578

)

Net income (loss) per diluted share (4)

$

(0.37

)

$

0.39

$

0.02

$

(0.31

)

$

0.29

$

(0.02

)

 
 

(1)

Acquired intangible assets amortization expense

6,954

5,518

Non-cash stock-based compensation expense

1,080

788

Restructuring and other related costs

15

310

Impairment charges

3,865

-

11,914

6,616

(2)

Acquired intangible assets amortization expense

2,218

2,200

Non-cash stock-based compensation expense

7,751

7,189

Restructuring and other related costs

-

350

Revaluation of investments

1,255

2,201

Contingent consideration

596

202

Other expenses

1,745

1,375

13,565

13,517

25,479

20,133

(3)

Corresponding tax effect and other expenses

81

(1,552

)

$

25,560

$

18,581

(4)

Weighted average number of ordinary
shares outstanding - Diluted

66,568

67,070

64,908

64,908

Six Months Ended June 30,

2022

Non-GAAP

2022

2021

Non-GAAP

2021

GAAP

Adjustments

Non-GAAP

GAAP

Adjustments

Non-GAAP

U.S. dollars and shares in thousands (except per share amounts)

Gross profit (1)

$

137,070

$

19,603

$

156,673

$

118,847

$

13,685

$

132,532

Operating income (loss) (1,2)

(43,129

)

47,086

$

3,957

(41,082

)

35,918

$

(5,164

)

Net income (loss) (1,2,3)

(45,333

)

47,718

$

2,385

(39,070

)

33,692

$

(5,378

)

Net income (loss) per diluted share (4)

$

(0.69

)

$

0.73

$

0.04

$

(0.63

)

$

0.54

$

(0.09

)

 
 

(1)

Acquired intangible assets amortization expense

13,920

10,873

Non-cash stock-based compensation expense

1,980

1,422

Restructuring and other related costs

(162

)

1,390

Impairment charges

3,865

-

19,603

13,685

(2)

Acquired intangible assets amortization expense

4,443

4,393

Non-cash stock-based compensation expense

15,384

13,760

Restructuring and other related costs

555

2,159

Revaluation of investments

2,316

(1,469

)

Contingent consideration

803

393

Other expenses

3,982

2,997

27,483

22,233

47,086

35,918

(3)

Corresponding tax effect and other expenses

632

(2,226

)

$

47,718

$

33,692

(4)

Weighted average number of ordinary
shares outstanding - Diluted

66,151

67,071

61,796

61,796

Stratasys Ltd.
 
Reconciliation of GAAP to Non-GAAP Forward Looking Guidance
 
Fiscal Year 2022
 
(in millions, except per share data)
 
 
GAAP net loss

($78) to ($69)

Adjustments
Stock-based compensation expense

$33 to $35

Intangible assets amortization expense

$37 to $38

Reorganization and other

$14 to $16

Tax expense (benefit) related to Non-GAAP adjustments

($2) to ($1)

Non-GAAP net income

$10 to $13

GAAP loss per share

($1.17) to ($1.04)

Non-GAAP diluted earnings per share

$0.14 to $0.19

Yonah Lloyd CCO, VP Investor Relations Yonah.Lloyd@stratasys.com

Source: Stratasys Ltd.